Which of the following conditions is most likely to cause a denial under Medicare guidelines for cancer treatment?

Prepare for the NHA Certified Billing and Coding Specialist (CBCS) Exam with engaging quizzes. Study with multiple choice questions, each offering hints and explanations, to enhance your understanding and readiness for the exam!

Multiple Choice

Which of the following conditions is most likely to cause a denial under Medicare guidelines for cancer treatment?

Explanation:
Medicare coverage for cancer treatment relies on treatments being proven, medically necessary, and FDA-approved for use in typical care. An experimental chemotherapy medication is not FDA-approved for general use and hasn’t established the standard of care Medicare expects. Because of that, it is likely to be denied unless the patient is participating in a qualifying clinical trial, where certain routine costs can be covered. In contrast, therapies that are FDA-approved and used as standard care—such as standard chemotherapy, surgery when indicated, and immunotherapies that have FDA approval—are typically covered when they are appropriate for the cancer and medically necessary.

Medicare coverage for cancer treatment relies on treatments being proven, medically necessary, and FDA-approved for use in typical care. An experimental chemotherapy medication is not FDA-approved for general use and hasn’t established the standard of care Medicare expects. Because of that, it is likely to be denied unless the patient is participating in a qualifying clinical trial, where certain routine costs can be covered. In contrast, therapies that are FDA-approved and used as standard care—such as standard chemotherapy, surgery when indicated, and immunotherapies that have FDA approval—are typically covered when they are appropriate for the cancer and medically necessary.

More Multiple Choice Questions
Subscribe

Get the latest from Passetra

You can unsubscribe at any time. Read our privacy policy